CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CDXS — Codexis, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CDXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$547,396
+$152,593 QoQ
Shares Held
242,211
0.0% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. CDXS ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CDXS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $547,396 | 242,211 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $394,803 | 242,211 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $448,083 | 274,898 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $611,786 | 250,732 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $611,771 | 250,726 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $673,172 | 250,250 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,143,464 | 239,720 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $658,097 | 213,668 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $662,057 | 213,567 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $713,893 | 204,554 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $645,788 | 211,734 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $288,049 | 152,407 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,644,728 | 587,403 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,616,769 | 632,070 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,928,255 | 628,381 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,712,768 | 612,668 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,960,536 | 569,841 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,327,741 | 549,357 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,133,789 | 451,992 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,573,397 | 411,582 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,023,665 | 398,220 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,852,295 | 386,732 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,958,563 | 364,570 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,028,616 | 343,153 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,858,580 | 338,472 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,526,392 | 315,985 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||